Narrative Review of Potential Non-Surgical Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Sung Han Kim1, Haarika Gudlavalleti1, Seth P Lerner1

  • 1Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Summary

Bacillus Calmette-Guérin (BCG) therapy is standard for non-muscle invasive bladder cancer (NMIBC). This review explores bladder preservation strategies for BCG-unresponsive NMIBC, offering alternatives to radical cystectomy.

Related Concept Videos